PSPG/CERSI Seminar Series 2016-2017
- Monthly, Every 2nd and 4th Tuesday, 12:00 - 1:00 PM
- Mission Bay, Rock Hall, RH-102
- Simulcast to Parnassus, N-225
Richard Lalonde, Pharm.D.
|Quantitative Clinical Pharmacology and Drug Development Strategy||Natalia Khuri|
Margaret Porter Scott, Ph.D.
|Novel technologies for the discovery of the next generation of medicines||Ken Hallenbeck|
Gai Ayalon, Ph.D.
|Untangling Tau: Targeting tau with antibodies for Alzheimer's disease||Nadav Ahituv|
Adrian Ray, Ph.D.
|Clinical relevance and complexity of renal transport pathways||Les Benet|
Lara Mangravite, Ph.D.
|Open ecosystems for systems biology applications in pharmaceutical science||Deanna Kroetz|
Kelly Dooley, Ph.D.
Johns Hopkins University School of Medicine
|Tuberculosis- using translational and clinical pharmacology to accelerate treatment optimization||Rada Savic|
Alex Sparreboom, Ph.D.
Ohio State University
|Kinase-mediated regulation of ADME associated proteins||Deanna Kroetz|
Marc Caron, Ph.D.
|Physiological and Therapeutic Implications of GPCR Functional Selectivity||Brian Shoichet|
Frank Weichold, Ph.D.
|Trends in Regulatory Science||Rui Zhang|
Steven Kern, Ph.D.
|Bringing Innovation in Drug Development Science to Global Health: is this possible when target cost are $1 ?||Natalia Khuri|
Peter Senter, Ph.D.
|Antibody-Drug Conjugates for Cancer Therapy||Sourav Bandyopadhyay|
Paula Hammond, Ph.D.